-
121
Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme
Published 2014-06-01“…One of the viable options for inhibiting the activity of neuraminidase- 1 is peptide drug design. In order to increase peptide stability, cyclization is necessary to prevent its digestion by protease enzyme. …”
Get full text
Article -
122
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
Published 2025-01-01“…In the 21st century, thanks to advances in biotechnology and developing pharmaceutical technology, significant progress is being made in effective drug design. Drug targeting aims to ensure that the drug acts only in the pathological area; it is defined as the ability to accumulate selectively and quantitatively in the target tissue or organ, regardless of the chemical structure of the active drug substance and the method of administration. …”
Get full text
Article -
123
Combating antibiotic resistance: mechanisms, challenges, and innovative approaches in antibacterial drug development
Published 2025-01-01“…Innovative approaches, such as structure-based drug design, combination therapies, and new delivery systems, are highlighted for their potential to create compounds with enhanced action against resistant strains. …”
Get full text
Article -
124
-
125
Inhibition of the SARS-CoV-2 Main Protease by Isoquercitrin γ-Cyclodextrin Inclusion Complex Formulations: A Biochemical and In Silico Study
Published 2023-01-01“…The main protease (Mpro) of SARS-CoV-2 is a well-established drug target for rational drug design of COVID-19 inhibitors. To address the serious challenge of COVID-19, we have performed biochemical inhibition screens with recombinantly expressed SARS-CoV-2 main protease (Mpro). …”
Get full text
Article -
126
-
127
-
128
-
129
Eccentric indices based QSPR evaluation of drugs for schizophrenia treatment
Published 2025-01-01“…Regardless of the significant developments in drug design, the fundamental approach still uses topological descriptors. …”
Get full text
Article -
130
Identification of an inter-cysteine loop potentially involved in the activity of Opisthorchis viverrini-granulin-1
Published 2023-06-01“…Aim: Identification of small bioactive regions in proteins and peptides can be useful information in drug design studies. The current study has shown that an inter-cysteine loop of the N-terminal domain of Opisthorchis viverrini granulin-1 (Ov-GRN-1), a granulin protein from the flatworm liver fluke Opisthorchis viverrini which has potent wound healing properties, maintains the bioactivity of the full-length protein. …”
Get full text
Article -
131
Molecular Characterization of Legionellosis Drug Target Candidate Enzyme Phosphoglucosamine Mutase from (strain Paris): An Approach
Published 2014-12-01“…However, these findings from this current study will pave the way for further extensive investigation of this enzyme in wet lab experiments and in that way assist drug design against legionellosis.…”
Get full text
Article -
132
-
133
-
134
Therapeutic effects of NAC and CoQ10 on aluminium phosphide poisoning as an adjuvant therapy: A Pilot study
Published 2025-06-01Get full text
Article -
135
Crotalaria madurensis flavonol glycosides’ antibacterial activity against Staphylococcus aureus
Published 2024-11-01Get full text
Article -
136
fragSMILES as a chemical string notation for advanced fragment and chirality representation
Published 2025-01-01“…Abstract Generative models have revolutionized de novo drug design, allowing to produce molecules on-demand with desired physicochemical and pharmacological properties. …”
Get full text
Article -
137
-
138
Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1
Published 2015-01-01“…These data could impact future strategies optimizing TLR7-targeted drug design.…”
Get full text
Article -
139
-
140
A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization—explanation of its folded conformation
Published 2025-01-01“…These findings suggest that PAPP could be a promising scaffold for future CML drug design, offering a potential alternative to existing TKIs, and PAPP1 is a promising lead susceptible to optimization.…”
Get full text
Article